Thursday, March 1, 2007 Whose Business is it Anyway? Science and the Corporate World.
In our modern world, science and private industry find themselves increasingly and inseparably linked. From pharmaceuticals through to theoretical physics, recent restructuring of public funding has accelerated this intimacy.
The results can be lucrative and our economy and prosperity depend on it. But what then happens to the objective 'purity' of scientific research that we trust to tell us the truth about our world? How objective can scientists be in the midst of this growing relationship between the laboratory and the market-place? Did such 'pure' scientists ever exist?
This session assembles a forum of leading experts drawn from the diverse domains of science research, bioethical enquiry and government regulation. We will explore the science/business interface, and what this changing relationship means for our trust in science.
Moderator: Francoise Baylis holds the Canada Research Chair in Bioethics and Philosophy (2004-2011) at Dalhousie University where she holds a cross-appointment in the Departments of Bioethics and Philosophy. She is Co-coordinator, with Susan Dodds, of the International Network on Feminist Approaches to Bioethics.
* Dr. Ford Doolittle is the Director of the Program in Evolutionary Biology of the Canadian Institute of Advanced Research; he holds a Canada Research Chair in Comparative Microbial Genomics, and is Professor in the Department of Biochemistry and Molecular Biology at Dalhousie University.
* Dr. Aled Edwards, senior research scientist, University of Toronto and CEO of the International Structural Genomics Consortium.
* Dr. Siddika Mithani is currently Director General of the Veterinary Drugs Directorate (VDD), Health Canada. She is a practicing pharmacist with a long and distinguished international career in the area of pharmaceutical assessment.